WHO issues guidance on GLP-1 drugs for obesity, calls them a “scientific breakthrough” and “new chapter”

The World Health Organization issued new guidelines Monday recommending the use of GLP-1 drugs for treating obesity. 

In the new guidelines, the United Nations health agency made two key recommendations — first, that GLP-1 therapies may…